Mirati Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MRTX and buy or sell other stocks, ETFs, and their options commission-free!

About MRTX

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. 

CEO
Charles M. Baum, MD, PhD
CEOCharles M. Baum, MD, PhD
Employees
Employees
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1995
Founded1995
Employees
Employees

MRTX Key Statistics

Market cap
4.12B
Market cap4.12B
Price-Earnings ratio
-4.80
Price-Earnings ratio-4.80
Dividend yield
Dividend yield
Average volume
2.31M
Average volume2.31M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$64.41
52 Week high$64.41
52 Week low
$27.30
52 Week low$27.30

People also own

Based on the portfolios of people who own MRTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.